| # | % | |||||
|---|---|---|---|---|---|---|
| 151 | AFFIMED N V COM | 294,213 | 730,000 | 0.03% | ||
| 152 | CELLDEX THERAPEUTICS INC NEW | 105,800 | 464,000 | 0.02% | ||
| 153 | XENCOR INC COM | 20,000 | 380,000 | 0.02% | ||
| 154 | RMR GROUP INC | 7,441 | 230,000 | 0.01% | ||
| 155 | ZAFGEN INC COM | 13,307 | 80,000 | 0.00% | ||
| 156 | ABBVIE INC | 156 | 10,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-139243, filed 2016.08.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.